[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fon0eLAjLL-iG1BQ3NdtkTsTLEA7kDAU5amQPTxzN7dI":8,"$fcIIG8lHCITaA0MJcMRc-78pSzNCYjRFqmpqs3vsgM_4":55,"$fEsSfs2fGRVA7IMXyTnv21xZxK7bI2DkdmqyfDmWAIVM":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},74137,867680,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","张欢","天津市第一中心医院","血液内科","主治医师",25,0,"深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗指南","","https://ystcdn.venuertc.com/venue/AI/3fc3bb2b-cca9-4762-9338-1c97919a32d0.jpg","\u003Cdiv class=\"drcool-container\">\n  \u003Ch1 id=\"material_title\" class=\"drcool-title\">深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗指南\u003C/h1>\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #f8fafc 60%, #e6f0f7 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">💡\u003C/span>什么是弥漫大B细胞淋巴瘤？\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        在日常生活中，很多人听说过“淋巴瘤”但未必知道具体类型。其实，弥漫大B细胞淋巴瘤（DLBCL）是非霍奇金淋巴瘤中最常见的一种。通俗来说，它是来源于淋巴细胞的一类癌症，主要见于中老年人。DLBCL的名字虽然有些拗口，但它背后的本质就是淋巴细胞（属于人体免疫系统的一部分）发生了异常增殖，使“防护系统”局部失控。\n      \u003C/p>\n      \u003Cp>\n        这类疾病有个特点：进展较快，需要及时关注。不过，现代医疗手段对其治疗已越来越成熟，早发现、早干预，恢复的几率就明显提升，对于患者和家人来说，科学认识这一疾病是很重要的第一步。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #fafbfc 60%, #f8e8f1 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">🔍\u003C/span>如何识别弥漫大B细胞淋巴瘤的症状？\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        早期的DLBCL症状并不容易被察觉。比如，有些人只是偶尔觉得脖子下、腋下或腹股沟摸到轻微的“包块”，没有疼痛感，往不会引起注意。有的人夜里出汗比平时多一点，或是感觉稍微有点乏力，这些也可能被误认为是普通疲劳。\n      \u003C/p>\n      \u003Cp>\n        不过，当淋巴瘤进展后，症状会变得明显。一些典型的信号包括：\u003Cstrong>肿块持续存在并逐渐变大，夜间盗汗变严重且影响睡眠，体重在短期内明显下降\u003C/strong>（比如半年内减轻5公斤以上），经常感觉无力，发热且持续时间较长。这些表现不是感冒或普通疾病造成时，建议及时去医院检查。\n      \u003C/p>\n      \u003Cp>\n        当下有一位65岁男性患者就是因为出现明显的持续肿块和夜间盗汗，在家人提醒下前往血液科就诊，后来被确诊为弥漫大B细胞淋巴瘤。\u003Cspan class=\"emoji\">🩺\u003C/span>这个例子说明，身上的“包块”如果反复存在或者与以往感觉完全不同，就不该大意。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #f6faf8 60%, #eafbf2 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">🧬\u003C/span>弥漫大B细胞淋巴瘤的致病机制和风险因素\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        DLBCL的产生其实和多种因素有关。首先，免疫系统的异常是一个核心。有调查发现，对于免疫力长期低下（比如器官移植后患者、HIV感染者）的人群，淋巴组织就更容易出现“异常细胞”。另外，随着年龄增长，体内细胞修复错误的风险逐渐上升，也给疾病创造了可乘之机。\n      \u003C/p>\n      \u003Cp>\n        家族遗传也是近期关注的方向。有研究报道，如果直系亲属中曾有人患此类淋巴瘤，后代发病率会明显高于一般人。环境因素也不可忽视，比如长期接触某些化学物质（如苯类）、农药或在放射性区域工作，都会增加隐患。\n      \u003C/p>\n      \u003Cp>\n        生活方式同样有影响。比如肥胖和慢性炎症，会让体内微环境长期处于“紧张”状态，这时候淋巴细胞的“自我修复”就可能出现差错。\u003Cspan class=\"emoji\">⚠️\u003C/span> 这些因素共同作用，类似“小工厂”里的隐患点，如果某些部位疏于监管，就容易出问题（比喻次数：1）。\n      \u003C/p>\n      \u003Cp class=\"drcool-quote\">\n        数据参考：Skibola, C.F., & Curry, J.D. (2014). Environmental exposures and lymphoma risk. Current Opinion in Hematology, 21(5), 459-467. \n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #f9f8fb 60%, #e3e9f8 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">📝\u003C/span>弥漫大B细胞淋巴瘤的诊断流程\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        如果怀疑有DLBCL的迹象，最关键的就是找对检查方法。一般医生会先详细询问个人和家族健康史，并做身体检查，特别是查看是否有异常肿块。\n      \u003C/p>\n      \u003Cp>\n        下一步常用的检查包括血常规、肝肾功能、乳酸脱氢酶（LDH）等基础化验。有时还需要拍摄彩超、CT或PET-CT，以了解肿块的分布和大小。但要最终确诊，还是得靠“病理活检”——也就是取出肿块的部分组织，在显微镜下看淋巴细胞是否异常。这样才能定位是哪一类型的淋巴瘤，为后续治疗提供依据。\n      \u003C/p>\n      \u003Cp>\n        一些患者担心活检会不会有风险。其实，微创手术下取活检已很成熟，恢复时间短。只要遵医嘱操作，可以大减少误诊或漏诊的可能性。\n      \u003C/p>\n      \u003Cp class=\"drcool-quote\">\n        数据参考：Cheson, B.D., Fisher, R.I., Barrington, S.F., et al. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma. Blood, 124(3), 332-335.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #f5fafc 60%, #f5e3e6 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">💊\u003C/span>治疗弥漫大B细胞淋巴瘤的常见方案\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        说到DLBCL的治疗，目前主要依靠化疗、免疫治疗和有时的放疗。最常用的是R-CHOP方案（含多种化疗药及靶向药物），通过抑制和消除异常淋巴细胞达到控制病情的目的。\n      \u003C/p>\n      \u003Cp>\n        靶向治疗逐渐成为亮点。部分患者如果有特殊基因变异，可以加用针对性药物，进一步提升疗效。不过，并非所有人都适合同一种方案，因此治疗前详细的分型和检验变得非常重要。\n      \u003C/p>\n      \u003Cp>\n        影像学监测和规律复查，是衡量治疗反应效果的重要步骤。一些早期患者可以达到完全缓解，部分人则需要反复巩固治疗。整体说来，只要积极配合医生，DLBCL的治愈率在非霍奇金淋巴瘤中排名靠前。\n      \u003C/p>\n      \u003Cp>\n        上面提到的那位65岁的男性患者，用化疗联合靶向药物治疗，5天住院期间有明显症状缓解，对生活影响减小。这说明合理治疗方案可以带来实际改善。\n      \u003C/p>\n      \u003Cp class=\"drcool-quote\">\n        数据参考：Habermann, T.M., & Weller, E.A. (2006). Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. The New England Journal of Medicine, 352(1), 14-24.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #fffef7 60%, #e4f4dd 100%);\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">🍏\u003C/span>日常生活如何管理弥漫大B细胞淋巴瘤？\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        治疗之外，生活管理同样重要。一个健康的作息、科学的营养支持和情绪调适，能帮助身体更好地恢复。比如，\u003Cspan class=\"drcool-food\">深色蔬菜+增强免疫+每餐均有\u003C/span>，\u003Cspan class=\"drcool-food\">鱼类（如三文鱼）+提供优质蛋白与不饱和脂肪+每周2-3次\u003C/span>，\u003Cspan class=\"drcool-food\">菌类（香菇、蘑菇）+辅助调节免疫功能+轮换添加\u003C/span>。科学研究也表明，合理摄入富含纤维与维生素的食物，有助于机体恢复。\n      \u003C/p>\n      \u003Cp>\n        规律作息，包括保证夜间7-8小时睡眠、中午适度休息，既能缓解化疗带来的疲劳，也能让机体自愈力发挥最大作用。运动方面，建议以快走、慢跑、太极为主，“量力而行”是关键。\n      \u003C/p>\n      \u003Cp>\n        情绪管理不能忽视，与家人朋友保持沟通，遇到情绪低落时可以尝试写日记、绘画等方式疏解。心理疏导和患者互助小组，也是不少康复者的选择。\n      \u003C/p>\n      \u003Cp>\n        出现持续高热、皮下出血点、剧烈腹痛等症状时，应尽快联系专业医生。选择血液专科的正规医疗机构，能为后续管理提供有力保障。\n      \u003C/p>\n      \u003Cp class=\"drcool-quote\">\n        数据参考：Smith, A., Howell, D., & Patmore, R. (2011). Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. British Journal of Cancer, 105(11), 1684-1692.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drcool-section\" style=\"background: linear-gradient(90deg, #fafbe6 60%, #bedbad 100%); margin-bottom:40px;\">\n    \u003Ch2 class=\"drcool-subtitle\">\u003Cspan class=\"emoji\">📘\u003C/span>科学理解，积极面对 —— 总结与行动建议\u003C/h2>\n    \u003Cdiv class=\"drcool-content\">\n      \u003Cp>\n        回头看，DLBCL虽然来势汹，但只要了解其信号，科学就医、规范治疗和做好生活管理，身体恢复的希望其实很大。专业的检查和个体化治疗，是控制疾病的关键一步；而日常里的营养搭配、规律休息和情绪支持，又悄为身体打下坚实基础（比喻次数：2）。\n      \u003C/p>\n      \u003Cp>\n        信息越充分，信心就越足。多关心家人和自己，遇到异常时尽早就医。其实健康管理就像日常保养自己的汽车，定期检查、及时修理，才能始终保持“路上无忧”（比喻次数：3）。希望这份指南，能帮你和家人一起科学面对，安心生活。\n      \u003C/p>\n      \u003Cdiv class=\"drcool-ref\">\n        \u003Cstrong>参考文献：\u003C/strong>\n        \u003Cul>\n          \u003Cli>Skibola, C.F., & Curry, J.D. (2014). Environmental exposures and lymphoma risk. \u003Cem>Current Opinion in Hematology\u003C/em>, 21(5), 459-467.\u003C/li>\n          \u003Cli>Cheson, B.D., Fisher, R.I., Barrington, S.F., et al. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma. \u003Cem>Blood\u003C/em>, 124(3), 332-335.\u003C/li>\n          \u003Cli>Habermann, T.M., & Weller, E.A. (2006). Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. \u003Cem>The New England Journal of Medicine\u003C/em>, 352(1), 14-24.\u003C/li>\n          \u003Cli>Smith, A., Howell, D., & Patmore, R. (2011). Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. \u003Cem>British Journal of Cancer\u003C/em>, 105(11), 1684-1692.\u003C/li>\n        \u003C/ul>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drcool-container {\n  max-width: 820px;\n  margin: 40px auto 0 auto;\n  background: #fafbfa;\n  border-radius: 10px;\n  box-shadow: 0 9px 24px 0 rgba(80,64,120,0.07);\n  padding: 0 30px 32px 30px;\n  font-family: \"PingFang SC\", \"Helvetica Neue\", Arial, \"Segoe UI\", \"Microsoft YaHei\", sans-serif;\n  color: #25304a;\n}\n.drcool-title {\n  font-size: 2.2rem;\n  color: #27477d;\n  margin-top: 38px;\n  margin-bottom: 38px;\n  text-align: center;\n  font-weight: 700;\n  letter-spacing: 2px;\n}\n.drcool-section {\n  margin-bottom: 34px;\n  border-radius: 10px;\n  padding: 28px 26px 24px 26px;\n  box-shadow: 0 2px 10px rgba(198,209,224,0.08);\n}\n.drcool-subtitle {\n  margin: 0 0 20px 0;\n  font-size: 1.4rem;\n  font-weight: 600;\n  display: flex;\n  align-items: center;\n  color: #304868;\n  letter-spacing: 1.2px;\n}\n.emoji {\n  margin-right: 12px;\n  font-size: 1.4em;\n}\n.drcool-content p, .drcool-content ul, .drcool-content li {\n  font-size: 1.08rem;\n  line-height: 1.95;\n  margin-top: 0;\n  margin-bottom: 16px;\n  word-break: break-all;\n  letter-spacing: 0.12em;\n}\n.drcool-content ul {\n  margin-left: 18px;\n  margin-bottom: 0;\n}\n.drcool-content li {\n  list-style: disc inside;\n}\n.drcool-food {\n  color: #257952;\n  background: #d0f7e6;\n  font-weight: 500;\n  padding: 1px 7px 1px 6px;\n  border-radius: 7px;\n  margin: 0 4px;\n  font-size: 1.01em;\n  display: inline-block;\n}\n.drcool-ref {\n  font-size: 1rem;\n  margin-top: 18px;\n  color: #78808d;\n  padding-left: 2px;\n  border-left: 4px solid #bbd7f7;\n  background: #f4faff;\n  border-radius: 7px;\n  overflow-x: auto;\n}\n.drcool-quote {\n  font-size: 0.97rem;\n  color: #7985a4;\n  background: #f2f6fa;\n  border-left: 4px solid #b6d9ee;\n  padding: 6px 0 6px 13px;\n  margin: 20px 0 0 0;\n  border-radius: 5px 0 0 5px;\n}\n@media (max-width: 740px) {\n  .drcool-container {\n    padding: 0 4vw 22px 4vw;\n  }\n  .drcool-section {\n    padding: 17px 8px 16px 12px;\n  }\n  .drcool-title {\n    font-size: 1.3rem;\n    margin-top: 16px;\n    margin-bottom: 16px;\n  }\n  .drcool-subtitle {\n    font-size: 1.08rem;\n  }\n  .drcool-content p, .drcool-content li {\n    font-size: 0.98rem;\n  }\n}\n\n\u003C/style>","\u003Cdiv class=\"drcool-container\">\n  \u003Ch1 id=\"material_title\" class=\"drcool-title\">深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗",555,"2025-11-26 00:39:32","弥漫大B细胞淋巴瘤, DLBCL, 非霍奇金淋巴瘤, 症状, 诊断, 治疗方案, 风险因素, 生活管理","本指南深入解析弥漫大B细胞淋巴瘤的症状、致病机制及治疗方法，助您科学识别和管理此疾病，提升康复希望。","2026-01-01 16:03:46",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]